TG Therapeutics
TGTX71
$34.44arrow_drop_up0.64%$0.21
High Growth
TGTX71
$34.44
arrow_drop_up0.64%Performance History
| Key Stats | |
|---|---|
| Open | $33.75 |
| Prev. Close | $34.24 |
| EPS | -0.10 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 33.66 | 34.79 |
| 52 Week Range | 6.46 | 41.92 |
| Ratios | |
|---|---|
| Earnings Growth % | - |
| EPS | -0.10 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About TG Therapeutics (TGTX)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Michael S. Weiss Esq.
- Headquarters
- Morrisville
- Employees
- 237
- Exchange
- NASDAQ
Keep an eye on TG Therapeutics
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is TG Therapeutics 's (TGTX) price per share?
The current price per share for TG Therapeutics (TGTX) is $34.44. The stock has seen a price change of $0.22 recently, indicating a 0.64% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for TG Therapeutics (TGTX)?
For TG Therapeutics (TGTX), the 52-week high is $41.92, which is 21.72% from the current price. The 52-week low is $6.46, the current price is 433.14% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is TG Therapeutics (TGTX) a growth stock?
TG Therapeutics (TGTX) has shown an average price growth of -1.65% over the past three years. It has received a score of 91 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying TG Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is TG Therapeutics (TGTX) stock price performance year to date (YTD)?
As of the latest data, TG Therapeutics (TGTX) has a year-to-date price change of 14.42%. Over the past month, the stock has experienced a price change of -9.34%. Over the last three months, the change has been 18.68%. Over the past six months, the figure is -1.79%. Looking at a longer horizon, the five-year price change stands at 57.7%.
help
Is TG Therapeutics (TGTX) a profitable company?
TG Therapeutics (TGTX) has a net income of $12.67M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 93.95% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 14.82% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $233.66M, although specific revenue growth data is currently not available. The gross profit is $219.53M. Operating income is noted at $20.63M. Furthermore, the EBITDA is $26.1M.
help
What is the market capitalization of TG Therapeutics (TGTX)?
TG Therapeutics (TGTX) has a market capitalization of $5.33B. The average daily trading volume is 34.22, indicating the stock's liquidity and investor engagement.